NovaBay Pharmaceuticals, Inc.
USD1.47
-0.48 (-24.62%)
CEO
Michael Kazley
IPO Date
2007-10-26
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
US
Open
$1.47
Prev. Close
$1.95
Day Low
$1.47
Day High
$1.47
52W Low
$1.11
52W High
$99.75
Market Cap
$0.04B
Volume
0.09M
| 39,925 |
| $0.00 |
| 3 Nov 2025 | Framework Ventures IV L.P. | 10 percent owner | C-Conversion | Acquired | 56,806,080 | $0.00 |
| 3 Nov 2025 | Framework Ventures IV L.P. | 10 percent owner | P-Purchase | Acquired | 2,702,703 | $0.01 |
| 3 Nov 2025 | R01 Fund LP | 10 percent owner | C-Conversion | Acquired | 56,806,080 | $0.00 |
| 3 Nov 2025 | R01 Fund LP | 10 percent owner | P-Purchase | Acquired | 2,702,703 | $0.01 |
| 3 Nov 2025 | Kazley Michael John | director, 10 percent owner, officer: Chief Executive Officer | C-Conversion | Acquired | 56,806,080 | $0.00 |
| 3 Nov 2025 | Kazley Michael John | director, 10 percent owner, officer: Chief Executive Officer | P-Purchase | Acquired | 2,702,703 | $0.01 |
| 20 Oct 2025 | Kazley Michael John | director, 10 percent owner, officer: Chief Executive Officer | A-Award | Acquired | 220,663 | $0.00 |
| 20 Oct 2025 | Kazley Michael John | director, 10 percent owner, officer: Chief Executive Officer | A-Award | Acquired | 134,375 | $0.00 |